• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

Research progress of GLP-2 in non-alcoholic fatty liver disease

Corresponding author: ZHANG Shujuan, suanju21@163.com
DOI: 10.12201/bmr.202502.00018
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Nonalcoholic Fatty Liver Disease (NAFLD) is an increasingly common chronic liver disease worldwide. It has become the most common chronic liver disease in adults and children. The incidence of NAFLD is increasing year by year and shows a trend of younger age. The occurrence of NAFLD is closely related to insulin resistance, obesity, type 2 diabetes and other metabolic syndromes. In recent years, glucagon-like peptide-2 (GLP-2), as a hormone specifically expressed in intestinal tissues, has been gradually discovered and paid attention to its role in insulin resistance and lipid metabolism. This article aims to review the research progress of GLP-2 in non-alcoholic fatty liver disease.

    Key words: Glucagon-like peptide-2; non-alcoholic fatty liver disease; Obesity Lipid metabolism; Insulin resistance; 

    Submit time: 13 February 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • NIU Xiao Shan. Advances in pharmacological studies of NF-κB involved in the regulation of nonalcoholic fatty liver disease. 2024. doi: 10.12201/bmr.202410.00006

    JIA Chen, GONG Yan, HAN Yijing, JIANG Jianan, LIU Weizheng, ZHANG Daxu, LU Wenping. Correlation between psychological stress and metabolic-associated fatty liver disease. 2022. doi: 10.12201/bmr.202204.00003

    Li Xue, Fei Yue, Xu Xiahong. Exploring the relationship between serum ferritin and metabolic-associated fatty liver disease in adolescents based on NHANES database. 2025. doi: 10.12201/bmr.202503.00012

    Zhang zhenwen. Effects of SGLT2 inhibitors on the metabolic syndrome and its components. 2025. doi: 10.12201/bmr.202503.00002

    Shen Zhe-jun, Zhu Guan-lin, Ye Fan, Yang Lian, Li Ming. Research Progress on the Impact of Dietary Fiber on Bone Metabolism through Short-Chain Fatty Acids. 2025. doi: 10.12201/bmr.202504.00008

    Ming-Dou Du. Study on the causal relationship between physical activity and insulin sensitivity. 2022. doi: 10.12201/bmr.202210.00027

    张楠, dujing. Research progress of O2O model in chronic disease management. 2024. doi: 10.12201/bmr.202407.00026

    Zhenghaijuan, NiuXiaohan. Research Progress of CCR and metabolic syndrome and its related diseases. 2025. doi: 10.12201/bmr.202501.00048

    TUO Chen-long, ZHANG De-hong, YANG Yang, GU Yu-biao, ZHANG Lei, GUO Jia-jun. Research Advances in P2X Ion Channels in Knee Osteoarthritis. 2025. doi: 10.12201/bmr.202502.00024

    shen pei cheng. Overview of TCM non-drug therapy of chronic kidney disease. 2024. doi: 10.12201/bmr.202409.00054

  • ID Submit time Number Download
    1 2024-12-13

    bmr.202502.00018V1

    Download
  • Public  Anonymous  To author only

Get Citation

王馨雨, ZHANG Shujuan. Research progress of GLP-2 in non-alcoholic fatty liver disease. 2025. biomedRxiv.202502.00018

Article Metrics

  • Read: 135
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误